Related Experiment Video
Updated: Feb 16, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
Published on: May 27, 2022
Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations
Sarah E Leyde1, Joseph O Merrill1, Anna J Treadway2
1Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Background:
Cannabis use is prevalent among patients receiving medication for opioid use disorder (MOUD). However, little is known about factors associated with frequent cannabis use.
Objective:
To describe correlates, patterns, and motivations for cannabis use among individuals treated with MOUD.
Methods:
Participants from a randomized trial (n = 303) investigating a mind-body intervention adjunct to MOUD were compared based on frequent cannabis use (≥3 days/week) versus less frequent or no use, assessing demographic and clinical characteristics. Individuals with frequent cannabis use were invited to participate in a telephone survey exploring reasons for cannabis use, cannabis usage in treating symptoms/conditions, route, tetrahydrocannabinol/cannabidiol content, and cannabis use disorder screening.
Results:
47.5% of participants (n = 144) endorsed cannabis use, and 27% used cannabis frequently (≥3 days/week). Frequent cannabis use was associated with anxiety (P = .04), nausea/vomiting (P < .001), and lower employment (P = .03). Employment was associated with less frequent cannabis use (OR = 0.54, 95% CI = 0.29-0.99, P = .049), and higher interoceptive awareness was associated with lower odds of frequent cannabis use (OR = 0.64, 95% CI = 0.43-0.96, P = .03). In a subsample (n = 27) of individuals with frequent cannabis use, 56% used cannabis for both recreation and symptom management, 30% for symptom management only, and 15% for recreation only. Participants who reported medical use of cannabis used it to manage a variety of conditions, including stress (100%), anxiety (83%), insomnia (79%), pain (75%), depression (75%), and posttraumatic stress disorder (n = 67%). Fifty-two percent wanted to cut down.
Conclusions:
Frequent cannabis use among individuals on MOUD was associated with anxiety, nausea, and lower employment, with no significant differences in key MOUD outcomes including substance use and retention. Individuals with frequent cannabis use reported treating stress, pain, and mental health conditions with cannabis. More attention to screening and treatment of these conditions is warranted.
Related Concept Videos
Correlations
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Secondary Motives: Power Motivation and Achievement Motivation
Power motivation is characterized by the desire to influence, control, or have an impact on others. It is shaped by an individual's experiences, social environment, and cultural context. People with high power motivation are...
Secondary Motives: Affiliation Motivation and Aggression Motivation
Opioid Receptors: Overview
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...

